Search results for "controlled"

showing 10 items of 2729 documents

The treatment of portal hypertension: a meta-analytic review.

1995

medicine.medical_specialtyClinical Trials as TopicHepatologybusiness.industryVascular diseaseMEDLINEHemorrhageVariceal hemorrhagemedicine.diseaseGastroesophageal variceslaw.inventionSurgeryVaricose VeinsText miningRandomized controlled triallawRecurrenceRisk FactorsMeta-analysisHypertension PortalmedicinePortal hypertensionHumansIntensive care medicinebusinessHepatology (Baltimore, Md.)
researchProduct

The necessity of placebo application in psychotropic drug trials.

1990

medicine.medical_specialtyClinical Trials as TopicPsychotropic DrugsPsychotherapistMEDLINEGeneral MedicinePlaceboClinical trialPlacebosPsychiatry and Mental healthPsychotropic drugmedicineHumansPharmacology (medical)PsychopharmacologyPsychiatryPsychologyDepression (differential diagnoses)Randomized Controlled Trials as TopicPharmacopsychiatry
researchProduct

Randomized Controlled Trials

2011

Background In clinical research, randomized controlled trials (RCTs) are the best way to study the safety and efficacy of new treatments. RCTs are used to answer patient-related questions and are required by governmental regulatory bodies as the basis for approval decisions.

medicine.medical_specialtyClinical researchRandomized controlled trialbusiness.industrylawAlternative medicinemedicineMEDLINEMedical physicsGeneral Medicinebusinesslaw.inventionDeutsches Ärzteblatt international
researchProduct

Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-sided Colon Cancer

2020

OBJECTIVE The aim of this prospective clinical study is to compare short-term outcome of laparoscopic right hemicolectomy using the Complete Mesocolic Excision (CME group) with patients who underwent conventional right-sided colonic resection (NCME group). SUMMARY BACKGROUND DATA Although CME with central vascular ligation in laparoscopic right hemicolectomy is associated with a significant decrease in local recurrence rates and improvements in cancer-related 5-year survival, there may be additional risks associated with this technique because of increased surgical complications. As a result, there is controversy surrounding its use. METHODS In this randomized controlled trial, several prim…

medicine.medical_specialtyColorectal cancerMEDLINEAnastomosislaw.inventionClinical study03 medical and health sciencesText mining0302 clinical medicineRandomized controlled triallawHumansMedicinelaparoscopic colonic resectionbusiness.industryGeneral surgerymedicine.diseaselaparoscopic surgeryTerm (time)SurgerySettore MED/18 - Chirurgia Generale030220 oncology & carcinogenesisColonic Neoplasmsright colon cancerFeasibility StudiesOperative timeLaparoscopy030211 gastroenterology & hepatologySurgerycomplete mesocolic excisionLymphSpecimen lengthbusinessLigationMesocolonAnnals of Surgery
researchProduct

Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus …

2010

Abstract Abstract 5164 Introduction: Using T2* MR a randomised placebo controlled study from Sardinia demonstrated combination therapy with deferiprone and desferrioxamine (DFP+DFO) significantly more effective than DFO in improving myocardial iron. One non-randomised study from Sardinia and one observational study from Greece seem to confirm for DFP+DFO therapy the most rapid clearance of cardiac iron. No data are available in literature about prospective comparisons on cardiac iron and function and liver iron in TM patients treated with DFP+DFO versus DFP and DFO in monotherapy. The aim of this multi-centre study was to assess prospectively in a large clinical setting the efficacy of the …

medicine.medical_specialtyCombination therapybusiness.industryThalassemiaImmunologyUrologyPlacebo-controlled studyCell BiologyHematologymedicine.diseaseBiochemistryDeferipronSurgeryBiventricular functionchemistry.chemical_compoundchemistrymedicineCardiac ironLiver ironDeferipronebusiness
researchProduct

Current state of dynamic surgery. A literature review.

2021

Background Recently, dental implant technology has been widely used for oral reconstruction. Dental implants are the treatment of choice for those patients with dental absences. An optimal implant placement is based on the prosthetic driven concept in order to achieve an aesthetic and functional restoration with a long-term prognosis. There are two types of guided implant surgery that are described in the literature: Static Guided Surgery (SGS) and Dynamic Guided Surgery (DGS). The aim of this study is to be aware of the current state of dynamic surgery and compare in the literature the discrepancies between planning and placement of dental implants. Material and Methods The study consists …

medicine.medical_specialtyComputer sciencemedicine.medical_treatmentMEDLINEContext (language use)frailtyReviewEsthetics DentalImplant surgerylaw.inventionhead and neck neoplasmsRandomized controlled triallawpostoperative complicationsmedicineHumansDental implantGeneral DentistryUNESCO:CIENCIAS MÉDICASDental ImplantsDental Implantation EndosseousmortalityOral reconstructionSurgeryImplant placementOtorhinolaryngologySurgeryImplantologyMedicina oral, patologia oral y cirugia bucal
researchProduct

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (…

2015

ABSTRACT The DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) aims to provide recommendations for definitions of time-to-event end points in cancer randomized controlled trials. We relied on a consensus method based on a multidisciplinary panel of experts to develop these guidelines for trials on sarcomas and gastrointestinal stromal tumors. Background The use of potential surrogate end points for overall survival, such as disease-free survival (DFS) or time-to-treatment failure (TTF) is increasingly common in randomized controlled trials (RCTs) in cancer. However, the definition of time-to-event (TTE) end points is rarely precise and lacks unif…

medicine.medical_specialtyConsensusTime FactorssarcomaDelphi TechniqueEndpoint Determination[SDV]Life Sciences [q-bio]Disease-Free Survivallaw.invention03 medical and health sciencesgastrointestinal stromal tumors0302 clinical medicineRandomized controlled trialSDG 3 - Good Health and Well-beinglawMultidisciplinary approachTerminology as TopicmedicineHumansMedical physicsTreatment Failureguidelinestime-to-event end pointComputingMilieux_MISCELLANEOUSRandomized Controlled Trials as Topic030304 developmental biologyEvent (probability theory)0303 health sciencesEnd pointGiSTSurrogate endpointbusiness.industryefficacy measureCancerHematologymedicine.disease3. Good healthOncologyResearch Design030220 oncology & carcinogenesisrandomized controlled trialDisease ProgressionRadiologySarcomabusiness
researchProduct

Systematic review of psychotherapeutic treatments for “minor” personality disorders

2011

IntroductionAmong personality disorders (PDs), antisocial and borderline personality disorder are well-studied. However, the remaining PDs (in the following called “minor PDs”) pose major problems in everyday-health care settings. People affected often present with additional axis-l disorders such as substance-related, mood or anxiety disorders, and are among those most difficult to treat.ObjectivesTo systematically review the current evidence of psychotherapeutic treatments for “minor” personality disordersMethodsIn the context of Cochrane Collaboration reviews for Cluster A, B and C PDs, exhaustive literature searches were done to identify the current RCT evidence for PD treatments. The e…

medicine.medical_specialtyContext (language use)Minor (academic)Disease clustermedicine.diseasePersonality disorderslaw.inventionPsychiatry and Mental healthMoodRandomized controlled triallawmedicineAnxietymedicine.symptomPsychologyPsychiatryBorderline personality disorderClinical psychologyEuropean Psychiatry
researchProduct

Home-Based Resistance Training for Older Subjects during the COVID-19 Outbreak in Italy: Preliminary Results of a Six-Months RCT.

2020

Background. The aim of this study was to evaluate the effect of a six-month home-based resistance-training program on muscle health and physical performance in healthy older subjects during the unique condition of home confinement caused by the COVID-19 pandemic. Methods. This was a randomized-controlled study that enrolled older participants that were allocated to either an experimental group performing the six-months exercise prescription (EXE) or a control group (CON). At the beginning (PRE), and after 6 months (POST), participants were assessed for muscle strength, balance, gait assessment and body composition by dual energy X-ray absorptiometry and magnetic resonance imaging. Normality…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Health Toxicology and Mutagenesislcsh:MedicineArticlelaw.inventionsarcopenia03 medical and health sciences0302 clinical medicinerisk of fallRandomized controlled triallawInternal medicineEpidemiologymedicineHumansmagnetic resonance imaging030212 general & internal medicineMuscle StrengthPandemicsBalance (ability)AgedAged 80 and overDXAexercisebusiness.industrylcsh:RagingPublic Health Environmental and Occupational HealthOutbreakCOVID-19Resistance TrainingMiddle Agedmedicine.diseaseItalySarcopeniaGait analysisCommunicable Disease ControlBody CompositionbusinessExercise prescription030217 neurology & neurosurgeryInternational journal of environmental research and public health
researchProduct

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

2021

Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses, and durations of therapy are being assessed in ongoing randomized controlled trials (RCTs) that focus on outpatients, hospitalized patients in medical wards, and patients critically ill with COVID-19. This paper provides a perspective of the ongoing or completed RCTs related to antithrombotic strategies used in COVID-19, the opportunities and challenges for the clinical trial enterprise, and ar…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrymedicine.drug_classAnticoagulantState of the art review030204 cardiovascular system & hematologymedicine.diseaseThrombosislaw.inventionClinical trial03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled triallawAntithromboticMedicine030212 general & internal medicineCardiology and Cardiovascular MedicinebusinessIntensive care medicineJournal of the American College of Cardiology
researchProduct